Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03119805 · ClinicalTrials.gov registry record

Remission and Flare in Psoriatic Arthritis: a Prospective 6-month Study With a Double Perspective.

A clinical trial of Psoriatic Arthritis, sponsored by Groupe Hospitalier Pitie-Salpetriere.

Completed
Registry status
466
Enrollment target
20
Study locations

NCT03119805 is a study of Psoriatic Arthritis that has completed, run by Groupe Hospitalier Pitie-Salpetriere. The registered enrollment target is 466 participants, below the 843-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (45% lower). The trial reports 20 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03119805, a study of Psoriatic Arthritis, has completed, sponsored by Groupe Hospitalier Pitie-Salpetriere.

COMPLETED
Registry status
466 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to define cut-off values of the most widely used composite scores and patient-reported outcomes, for levels corresponding to remission/low disease activity and for changes in levels corresponding to flares, in PsA, when remission/low disease activity and flare are defined from the patient and physician perspective. The ReFlaP (Remission/Flare in PsA) study is a prospective, multicentric international, longitudinal, observational study.

Conditions Studied

Psoriatic Arthritis

Study Locations (20)

Other

  • Smolen - Vienna
  • Palominos - Porto Alegre
  • Aydin - Ottawa
  • Sibel Aydin - Ottawa
  • Eder - Toronto
  • Talli - Tallinn
  • Soubrier - Clermont-Ferrand
  • Dernis - Le Mans
  • Laure Gossec - Paris
  • Richette - Paris
  • Ruyssen-Witrand - Toulouse
  • Uta Kiltz - Herne
  • Lubrano - Campobasso
  • Rossana Scrivo - Roma
  • Balanescu - Bucharest
  • Inna Gaydukova - Saratov
  • Katy Leung - Singapore
  • Juan Canete - Barcelona

Maryland

  • Ana- Maria Orbai - Baltimore

Ohio

  • Husni - Cleveland

Trial Details

FieldValue
Enrollment Target 466 participants
Start Date 2017-05-18
Est. Completion 2018-07-30

Sponsor

Groupe Hospitalier Pitie-Salpetriere

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03119805

The ClinicalTrials.gov registry entry for NCT03119805 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 466 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 843-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (45% lower). The listed sponsor is Groupe Hospitalier Pitie-Salpetriere, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Psoriatic Arthritis appearing as the primary indexed condition, and to 0 interventions.

NCT03119805 reports 20 study locations spanning 3 distinct geographic areas - top geographies include Other, Maryland, Ohio.

Frequently Asked Questions

What is clinical trial NCT03119805 about?

NCT03119805 is a clinical study titled "Remission and Flare in Psoriatic Arthritis: a Prospective 6-month Study With a Double Perspective.". The purpose of this study is to define cut-off values of the most widely used composite scores and patient-reported outcomes, for levels corresponding to remission/low disease activity and for changes in levels corresponding to flares, in PsA, when remission/low disease activity and flare are define...

What is the current status of trial NCT03119805?

This trial is currently completed. The enrollment target is 466 participants. The study started on 2017-05-18. Estimated completion is 2018-07-30.

What conditions does trial NCT03119805 study?

This clinical trial studies the following conditions: Psoriatic Arthritis.

Who is sponsoring clinical trial NCT03119805?

This trial is sponsored by Groupe Hospitalier Pitie-Salpetriere, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03119805 being conducted?

This trial has 20 study locations across Maryland, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Psoriatic Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Psoriatic Arthritis

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.